Entropy Technologies, LP Repligen Corp Transaction History
Entropy Technologies, LP
- $952 Billion
- Q3 2024
A detailed history of Entropy Technologies, LP transactions in Repligen Corp stock. As of the latest transaction made, Entropy Technologies, LP holds 2,500 shares of RGEN stock, worth $366,350. This represents 0.04% of its overall portfolio holdings.
Number of Shares
2,500
Previous 3,075
18.7%
Holding current value
$366,350
Previous $388 Million
4.02%
% of portfolio
0.04%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding RGEN
# of Institutions
488Shares Held
54.2MCall Options Held
341KPut Options Held
235K-
Black Rock Inc. New York, NY7.57MShares$1.11 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$937 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$739 Million0.01% of portfolio
-
State Street Corp Boston, MA1.62MShares$238 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.42MShares$208 Million1.34% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.13B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....